Skip to main content

Feeley Kevin's Form 4/A amendment

Amended

GeneDx Holdings Corp. (WGS) · filed May 9, 2025

Accession no.
0001415889-25-012579
Filed
May 9, 2025
Trade date
Apr 9, 2025
Filing delay
30 days
Rule 10b5-1 plan
Checked
Original filed
Apr 10, 2025

This filing lists 10 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.31M. It was filed 30 days after the trade.

This amendment replaces 0001415889-25-010536 (filed Apr 10, 2025).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Feeley KevinCIK 0001944119Officer (CHIEF FINANCIAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 9, 2025Class A Common StockMOption exerciseAcquired+1,246$32.67+$40,706.8217,242Direct
Apr 9, 2025Class A Common StockSSaleDisposed−637$83.67F2−$53,297.7916,605Direct
Apr 9, 2025Class A Common StockSSaleDisposed−1,198$84.61F3−$101,362.7815,407Direct
Apr 9, 2025Class A Common StockSSaleDisposed−1,171$85.73F4−$100,389.8314,236Direct
Apr 9, 2025Class A Common StockSSaleDisposed−249$86.48−$21,533.5213,987Direct
Apr 9, 2025Class A Common StockSSaleDisposed−5,993$93.28F5−$559,027.047,994Direct
Apr 9, 2025Class A Common StockSSaleDisposed−2,693$94.61F6−$254,784.735,301Direct
Apr 9, 2025Class A Common StockSSaleDisposed−1,463$95.53F7−$139,760.393,838Direct
Apr 9, 2025Class A Common StockSSaleDisposed−846$96.46F8−$81,605.162,992Direct
Apr 9, 2025Class A Common StockSSaleDisposed−20$97.26−$1,945.22,972Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 9, 2025Common StockMOption exerciseDisposed−1,246$0.00$07,473Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.

F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.07 to $84.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.13 to $84.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.25 to $86.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F5

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F6

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F7

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.04 to $96.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F8

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.07 to $96.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F9

6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Remarks

The original Form 4, filed on April 10, 2025, is being amended by this Form 4 to correct an administrative error which incorrectly reported the amount of Class A Common Stock sold in connection with the Reporting Person's stock option exercise. This Form 4 reflects updated Class A Common Stock shares sold in Box 4 of the Reporting Person's stock option exercise.

Read the full filing on SEC EDGAR (opens in a new tab)